Aprogen Biologics financial statements

에이프로젠바이오로직스KRX:003060 · KOSPI · Healthcare · sector #23
₩1,555-0.58%
2026-10-06 close

Aprogen Biologics's published financial data is dated 2026-10-04. 2024 revenue was KRW 67.38B. 2024 operating profit was −KRW 70.11B.

Reported results

Aprogen Biologics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q